Retagletide represents a novel strategy to controlling type 2 diabetes. This effective GLP-1 receptor agonist demonstrates encouraging results in clinical trials, underscoring its potential capability in augmenting glycemic control. Retagletide's uncommon mechanism of action involves attaching to GLP-1 receptors, initiating a cascade of events tha